|
|
|
|
|
|
|
|
In a recent paper in the Journal of the National Cancer Institute, clinical biochemist Eleftherios Diamandis uncovers some of bigger blunders in cancer-diagnosis techniques -- explaining how experimental data could be misinterpreted and how, as a result, once-touted breakthroughs turned out to be far less than met the eye. Diamandis spoke to TIME earlier this week about his findings, and about how fizzled hopes can affect medicine
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.